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Use of diffusion tensor imaging to assess the impact of normobaric
hyperoxia within at-risk pericontusional tissue after traumatic
brain injury
Tonny V Veenith1, Eleanor L Carter1, Julia Grossac1, Virginia F Newcombe1, Joanne G Outtrim1, Sridhar Nallapareddy1, Victoria Lupson2,
Marta M Correia2, Marius M Mada2, Guy B Williams2, David K Menon1 and Jonathan P Coles1
Ischemia and metabolic dysfunction remain important causes of neuronal loss after head injury, and we have shown that
normobaric hyperoxia may rescue such metabolic compromise. This study examines the impact of hyperoxia within injured brain
using diffusion tensor imaging (DTI). Fourteen patients underwent DTI at baseline and after 1 hour of 80% oxygen. Using the
apparent diffusion coefficient (ADC) we assessed the impact of hyperoxia within contusions and a 1 cm border zone of normal
appearing pericontusion, and within a rim of perilesional reduced ADC consistent with cytotoxic edema and metabolic
compromise. Seven healthy volunteers underwent imaging at 21%, 60%, and 100% oxygen. In volunteers there was no ADC change
with hyperoxia, and contusion and pericontusion ADC values were higher than volunteers (Po0.01). There was no ADC change
after hyperoxia within contusion, but an increase within pericontusion (Po0.05). We identified a rim of perilesional cytotoxic edema
in 13 patients, and hyperoxia resulted in an ADC increase towards normal (P¼ 0.02). We demonstrate that hyperoxia may result in
benefit within the perilesional rim of cytotoxic edema. Future studies should address whether a longer period of hyperoxia has a
favorable impact on the evolution of tissue injury.
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INTRODUCTION
Cerebral ischemia and metabolic dysfunction remain important
causes of neuronal loss after traumatic brain injury (TBI).1 We have
previously used 15O positron emission tomography to show that
normobaric hyperoxia increases oxygen utilization in ‘at-risk’
regions of metabolically compromised tissue, typically in
pericontusional regions and white matter.2 Such improvements
in oxidative metabolism may result through the alleviation of
physiologic and metabolic compromise linked to a range of
pathophysiological processes. These include classic ischemia,
increased diffusion barriers to oxygen delivery associated
with microvascular ischemia, and mitochondrial dysfunction.2,3
However, while previous studies demonstrate a consistent effect
of hyperoxia in increasing brain tissue oxygen levels, reports of the
impact on brain metabolism have been inconsistent, regionally
variant, and dependent on the underlying metabolic state of the
tissue concerned.2,4 Additional concerns have been raised
regarding the potential deleterious effects on pulmonary
function and worsening of neuronal injury because of oxidative
stress.5,6 Studies within other pathologies such as stroke and
myocardial infarction have also shown conflicting evidence of
benefit and harm.7,8 Given this background, it is clear that further
study of the regional effects of normobaric hyperoxia is warranted
before definitive clinical trials of the intervention after TBI.
Diffusion tensor imaging has shown benefit in a variety of
neurologic disease states in predicting both local tissue and
functional outcome.9,10 Studies after TBI have demonstrated
evidence of traumatic axonal injury that is not evident using
conventional imaging techniques.10 Diffusion tensor imaging (DTI)
images dynamic metabolic processes, including cytotoxic edema
associated with cellular metabolic failure, and experience in stroke
shows that these imaging changes are dynamic and reversible,
suggesting that they may be able to image acute treatment
effects. We have therefore used DTI to assess the impact of
normobaric hyperoxia in this context, and provide data for the
planning and design of future therapeutic trials of hyperoxia
therapy for patients with head injury.
MATERIALS AND METHODS
Ethical approval was obtained from the Cambridgeshire Research Ethics
Committee (reference numbers 97/290 and 02/293), and written informed
consent, or consultee agreement from next-of-kin where appropriate, were
obtained in all cases in accordance with the Declaration of Helsinki.
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Subjects
Patients. Fourteen adult patients (12 males and 2 females) with mean
(range) age 41 (21 to 70) years with head injury were recruited from the
Neurosciences Critical Care Unit, Addenbrooke’s Hospital, Cambridge, UK
between 2010 and 2012. Patients presented with median (range)
postresuscitation Glasgow coma score of 7 (3 to 14), but deteriorated to
a Glasgow coma scoreo8 requiring sedation and ventilation for control of
intracranial pressure (ICP; Table 1). Patients were recruited to this imaging
study between day 1 and day 9 after injury and underwent imaging while
sedated. Patients were excluded from this study if they had suffered a
previous TBI, other neurologic disease, or had any contraindication to
magnetic resonance imaging All patients were managed by protocol-
driven care; which included sedation, paralysis, and ventilation to ensure
that ICPo20mmHg and cerebral perfusion pressure 465mmHg were
maintained.2 Physiologic stability was meticulously ensured during
imaging through the titration of fluids and vasoactive agents and the
presence of a critical care physician and nurse. Patients who received
surgical intervention (cerebrospinal fluid drainage or decompressive
craniectomy) or second-tier medical therapies (barbiturate coma or
moderate hypothermia (33 to 35 1C)) before imaging are specified in
Table 1. No other major changes occurred in the management of patients
on the day of study.
After acquisition of baseline diffusion tensor imaging (DTI) at a partial
pressure of oxygen (PaO2) of approximately 75 to 90 torr (10 to 12 kPa), the
fraction of inspired oxygen (FiO2) was increased to a maximum of 0.8 to
achieve a PaO2 of approximately 225 to 260mmHg (30 to 35 kPa). After a
60-min period to allow impact of higher PaO2 (and by inference, brain pO2)
levels on cerebral metabolism, repeat DTI was obtained within the same
imaging session without moving the patient.
Controls. Seven controls (four females and three males) with a mean
(range) age of 31 (22 to 42) years were exposed to graded oxygen therapy
(21%, 60%, and 100% inspired oxygen) delivered via a venturi mask
(Flexicare Medical Limited, Mid Glamorgan, Wales, UK). Diffusion tensor
imaging was obtained at each level after an equilibration period of 15min
to assess the impact of oxygen therapy on normal brain.
Imaging
All subjects were scanned using a 3T Siemens Verio magnetic resonance
imaging scanner (Siemens AG, Erlangen, Germany) within the Wolfson
Brain Imaging Centre (WBIC), University of Cambridge. During the study
period there were no major changes or upgrades to the scanner or
software. The sequences obtained were structural sequences including a
three-dimensional T1-weighted magnetization prepared rapid gradient
echo, fluid-attenuated inversion recovery (FLAIR), gradient echo, suscept-
ibility-weighted images, and dual spin echo (proton density/T2-weighted).
The DTI data were acquired using 63 noncollinear directions, b¼ 1,000 s/mm2
with one volume acquired without diffusion weighting (b¼ 0), echo
time (TE) 106ms, repetition time (TR) 11,700ms, 63 slices, field of view
192mm 92mm, 2mm3 isotropic voxels, and an acquisition time of
13:50min. All acquired images were reviewed by a specialist neuroradiol-
ogist as a part of clinical care.
Image processing. Apparent diffusion coefficient (ADC) maps were
created using the Oxford Centre for functional magnetic resonance
imaging of the brain FSL Diffusion Toolbox.11 To aid coregistration, the
skull and extracranial soft tissue were stripped from the T1-weighted
image using the Brain Extraction Tool of FSL.12 The diffusion-weighted data
were normalized using a two-step approach. First, T1-weighted images
were coregistered to the Montreal Neurological Institute 152 (MNI152)
template using the vtkCISG normalized mutual information algorithm. The
b¼ 0 image was subsequently coregistered to the subject’s own T1-
weighted image. The transformation matrix normalizing the magnetization
prepared rapid gradient echo was then applied to the b¼ 0 image. All
coregistered and normalized images were visually checked to ensure that
they were aligned.
Region-of-Interest Analysis
Standard template in controls. Regions of interest (ROIs) from the Harvard
Oxford subcortical and MNI structural probabilistic atlases available within
FSL were applied in normalized space.13 These included the corpus
callosum, midbrain, forceps minor, and forceps major, and bilateral regions
covering the frontal, temporal, occipital, and parietal lobes, and the
caudate, thalamus, hippocampus, cerebral peduncle, pons, cerebellum,
anterior thalamic radiation, superior longitudinal fasciculus, inferior
longitudinal fasciculus, cingulum, uncinate fasciculus, and corticospinal
tracts. All coregistered images were inspected to ensure that the ROIs were
aligned and corresponded to the regions specified. The ROI template was
modified by erosion of a single voxel using fslmaths to improve spatial
localization and reduce the impact of coregistration, normalization, and
partial volume errors. The ADC values for the different ROIs were calculated
using in-house software using Matlab (Mathworks, Natick, MA, USA).
Lesion-based analysis in patients. Lesions were defined in native FLAIR
space by a single author (JG), and segregated into regions defined as core,
contusion, and pericontusion using patient FLAIR, magnetization prepared
Table 1. Patient characteristics
Subject Age Sex Mechanism Injury GCS Marshall
score
APACHE
II
ISS Neurosurgery Second-tier
therapies
Days
to
MRI
GOS
1 53 M RTA Multiple contusions
and DAI
4 NEML 17 34 — 4 MD
2 34 M RTA tSAH, SDH and IVH 4 NEML 21 20 EVD 3 VS
3 34 M Assault Multiple contusions 8 EML 25 16 DC 3 SD
4 21 M RTA Multiple contusions 10 NEML 21 50 — Hypothermia 2 MD
5 31 M RTA Multiple SDH 6 EML 17 29 DC 1 MD
6 29 M Assault Multiple contusions 10 EML 17 16 DC, EVD Hypothermia 2 GR
7 58 M Fall Multiple contusions 10 NEML 20 34 — — 4 GR
8 26 M RTA SDH and Multiple
contusions
3 NEML 17 75 — 3 MD
9 28 M Assault SDH and EDH 12 EML 24 36 DC 3 GR
10 61 M Fall Multiple contusions 5 NEML 22 75 — 9 Not
available
11 60 M Fall Multiple contusions 14 NEML 8 34 — — 3 MD
12 31 F Fall Multiple contusions 3 EML 25 75 DC Hypothermia 4 VS
13 70 F RTA Multiple contusions 3 NEML 21 34 — 1 GR
14 27 M RTA Multiple contusions 7 NEML 16 25 — 4 GR
DAI, diffuse axonal injury; DC, decompressive craniectomy; EDH, extradural hemorrhage; EML, evacuated mass lesion; EVD external ventricular drain; F, female;
GCS, Glasgow coma score; GOS, Glasgow outcome score; GR, good recovery; IVH, intraventricular hemorrhage; M, male; MD, moderate disability; MRI,
magnetic resonance imaging; NEML, non evacuated mass lesion; RTA, road traffic accident; SD, severe disability; SDH, subdural hemorrhage; tSAH, traumatic
subarachnoid hemorrhage; VS, vegetative state.
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rapid gradient echo, gradient echo, and susceptibility-weighted images.
Lesion core was identified as a region of mixed signal intensity consistent
with hemorrhage and necrotic tissue, contusion as an area of high signal
on FLAIR, and pericontusion as a 1-cm border zone of tissue surrounding
the contusion (Figure 1). Where visible, we also defined a rim of cytotoxic
edema (‘traumatic penumbra’) on ADC images that we have previously
reported around contusions using DTI (Figure 2).9 The ROIs were drawn
using Analyze 8.5 (Analyze Direct, Lenexa, KS, USA). FLAIR images were
coregistered to T1 space using SPM8, and the coregistration matrix
subsequently applied to the individual lesion ROIs. For comparison, a
comparable region of brain composed of mixed gray and white matter was
defined in controls.14
Statistical analysis. Statistical analyses were conducted using Statview
(Version 5, 1998, SAS Institute, Cary, NC, USA). All data are expressed and
displayed as mean and standard deviation (s.d.), unless otherwise stated.
Individual ROIs were treated independently, as they represented a clinically
relevant method of segmenting the brain, with specific location being
irrelevant to this analysis. Data were compared using unpaired and paired
t-tests and analysis of variance. All P-values are quoted after Bonferroni
corrections (where appropriate), and corrected P-values o0.05 were
considered significant.
RESULTS
Impact of Oxygen Therapy on Diffusion Tensor Imaging in Healthy
Volunteers
There was no significant ADC change using the standard template
ROI for an increase in the inspired fraction of oxygen (FiO2)
(P40.99, analysis of variance). The mean (s.d.) ADC was
8.98 10 4 (1.37 10 4), 9.21 10 4 (1.37 10 4) and
9.20 10 4 (1.35 10 4)mm/second for an FiO2 of 0.21, 0.6,
and 1.0, respectively.
Injured brain regions. The mean (s.d.) ADC in contusional and
pericontusional ROIs was 1.11 10 3 (1.41 10 4) and
1.08 10 3 (1.79 10 4), respectively, and was significantly
higher than controls (9.21 10 4 (2.78 10 5, Po0.01, analysis
of variance with Bonferroni correction)). There was no significant
change in ADC after hyperoxia within contusional ROIs (P¼ 0.16,
paired t-test), but an increase within pericontusional ROIs
(P¼ 0.02, paired t-test). One subject with low pericontusional
ADC showed an increase to within the normal range. The data are
displayed compared with the mixed gray and white matter region
from controls (Figure 3).
There was a rim of low ADC around brain contusions consistent
with cytotoxic edema in 13 subjects with a mean (range) volume
of 8 (1 to 20)ml (Figure 2). There was a significant increase in ADC
towards the normal range (7.04 10 4 versus 8.28 10 4
P¼ 0.02, paired t-test). The data are displayed compared with a
mixed gray and white matter region from controls, and shows that
while all subjects demonstrate an increase this is to within or more
than the normal range in four subjects (Figure 4).
DISCUSSION
In this study we used DTI to examine whether an increase in the
fraction of inspired oxygen had any beneficial effects within the
injured brain. We found no significant change in healthy
volunteers and no evidence of benefit within lesion brain
identified on structural imaging. The rim of cytotoxic edema that
we have previously defined as a region of ‘traumatic penumbra’
around brain contusions9 demonstrated a significant increase in
ADC values towards normal. While an increase in the fraction of
inspired oxygen has been reported to increase brain tissue partial
pressure of oxygen, reduce microdialysis lactate and lactate
pyruvate ratio,2,15,16 and improve brain metabolism17,18; we show
evidence of benefit within ‘at-risk’ traumatic penumbral regions of
the injured brain. While these data are provisional, they provide a
Figure 1. Lesion regions of interest. Fluid-attenuated inversion
recovery (FLAIR) and apparent diffusion coefficient (ADC) images
with lesion core (red), contusion (green), and perilesion (yellow)
identified on a single axial slice.
Figure 2. Traumatic penumbra. Fluid-attenuated inversion recovery
(FLAIR), gradient echo, and apparent diffusion coefficient (ADC)
images at normoxia and hyperoxia demonstrating contusions within
the left frontal and temporal parietal regions. These lesions have a
hemorrhagic core shown by low signal on the gradient echo
corresponding to the presence of blood degradation products,
surrounded by a region of ‘vasogenic edema’ with high signal on
FLAIR and ADC. Around these lesions is a hypointense rim
consistent with ‘cytotoxic edema’, an example of which is shown
at higher magnification and identified by the arrows. The final image
has a color map showing the ADC increase calculated from the
difference between the ADC images after hyperoxia. This highlights
that the increase in ADC occurs predominantly within this border
zone immediately surrounding the contusions.
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framework to use DTI as an intermediate endpoint to assess the
impact of changes in brain oxygenation and metabolism on lesion
expansion and local tissue outcome over time within the injured
brain. Further studies should address whether there is benefit in
using hyperoxia therapy over a longer period of days in patients
with head injury.
As oxygen has a known paramagnetic effect19 and could, in
theory, result in signal change within the MR data we exposed
healthy volunteers to three levels of oxygen and conducted DTI at
each level. The venturi oxygen masks that we used may not have
provided a fixed level of PaO2, particularly for oxygen flow rates
adjusted to achieve an FiO2 of 1.0.
20 However, at each level of
inspired oxygen, PaO2 would have been higher in the volunteers
and while we do not know the absolute PaO2 achieved it would
be comparable to the patients who had a maximum FiO2 of 0.8 to
achieve a PaO2 of 225 to 260mmHg (30 to 35 kPa). Indeed, the
patients all had a degree of lung injury or pathology consistent
with trauma and several days of mandatory ventilation. We did
not monitor arterial blood gases in the healthy volunteers as the
absolute PaO2 is not relevant in this case, rather a step increase in
oxygenation (baseline, intermediate and maximum) did not result
in any consistent change in DTI signal that could explain the result
in patients.
Previous studies have demonstrated that patients with an
increase in the severity, number, and duration of episodes of
tissue hypoxia tend to suffer poor outcome after head injury21 and
evidence suggests that therapy guided by measurement of
brain tissue oxygen levels may be associated with improved
outcome.21,22 Interventional studies have demonstrated that an
increase in the fraction of inspired oxygen can result in
improvements in brain tissue oxygen levels,15,23 and reductions
in brain lactate using microdialysis.2,16,23 While significant, the
changes in lactate did not necessarily result in an improvement in
oxidative metabolism as the lactate/pyruvate was not consistently
lowered.
The effects that result from an improvement in tissue oxygena-
tion are clearly dependent on oxygen delivery and (probably)
diffusion gradients in the injured brain.24 Pathophysiological
derangements within the injured brain are spatially variant and
are not limited to regions that appear structurally injured.1,3,25
Therefore, adequate definition of the effects of hyperoxia across
the injured brain demands measurement of regional and global
cerebral metabolism using a physiologic imaging technique such
as15oxygen positron emission tomography. An 15O positron
emission tomography study showed that ventilation with 100%
oxygen in a group of five patients within 24 hours of severe head
injury resulted in no change in hemispheric cerebral blood flow or
oxygen metabolism (CMRO2).
26 These results are in contrast to a
further study that demonstrated that a brief intervention (B1
hour) of normobaric hyperoxia resulted in an increase of CMRO2
within brain regions at the greatest risk of infarction.2 This analysis
included perilesional and white matter regions of the injured
brain. While these data suggest that the impact of hyperoxia may
be dependent on the underlying physiologic characteristics of
different regions of the injured brain, another study using near-
infrared spectroscopy has suggested that short-term therapy with
hyperoxia can improve oxygen metabolism within a frontal brain
region.17
An explanation for these findings comes from postmortem
studies showing widespread microvascular occlusion and perivas-
cular edema after TBI, associated with selective neuronal loss.27,28
The relevance of these findings to clinical ischemia is explained by
15O positron emission tomography and brain tissue oximetry
studies, which show increased vascular to tissue gradients for
oxygen tension in the injured brain.3 We have previously used DTI
to demonstrate contusion expansion,9 and that a rim of low ADC
consistent with cytotoxic edema is often found surrounding a
region of high ADC (vasogenic edema). This rim of hypodensity
may characterize a region of microvascular failure resulting in
cytotoxic edema, and represent a ‘traumatic penumbra’ that may
be rescued by effective therapy or be subsumed as the contusion
enlarges. Higher brain oxygen levels may overcome diffusion
barriers to oxygen delivery, or compensate for mitochondrial
dysfunction. Indeed, in regions of low oxygen tension, nitric oxide
can competitively inhibit cytochrome oxidase and thereby render
mitochondrial respiration dependent on the level of cellular
oxygen.29 Ex vivo studies in clinical and experimental head injury
tissue show impaired function in mitochondria (typicallyo4 hours
of injury).30,31 Experimental data also show that mitochondrial ATP
production is preserved, and that this is associated with improved
cognitive recovery and reduced neuronal cell loss in the
hippocampus after injury and treatment with hyperbaric and
Figure 3. Lesion-based analysis. Apparent diffusion coefficient (ADC)
within brain tissue identified as contusion (A) and pericontusion (B)
at baseline and after normobaric hyperoxia. The shaded gray box
represents the 95% confidence interval for healthy controls from a
region of mixed gray and white matter.
Figure 4. Impact of hyperoxia within traumatic penumbra. Changes
in apparent diffusion coefficient (ADC) for the rim of cytotoxic
edema surrounding visible brain lesions in 13 subjects. The shaded
gray box represents the 99% confidence interval for healthy controls
from a region of mixed gray and white matter.
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normoxic hyperoxia.32 Experimental data also report that hyper-
oxia has neuroprotective and antiinflammatory effects within the
injured and ischemic brain.33 Our clinical data are suggestive of a
normalization of ADC values in such regions after a brief period of
hyperoxia. However, we have no data on whether such an
increase is beneficial in terms of preventing lesion expansion and
improving functional outcome. Indeed, in two subjects the
increase in ADC was greater than the 95% confidence interval
for controls and could reflect tissue injury.
Although the use of high partial pressures of oxygen may be
beneficial in a variety of disease states and after brain injury, there
may be a relatively narrow margin of safety because of the known
toxic effects. The maximum FiO2 in this interventional study was
limited to 0.8 to reduce potential side effects including alveolar
atelectasis and pulmonary injury. However, clinical studies in TBI
have used short exposures of normobaric and hyperbaric
hyperoxia and failed to demonstrate increased oxidative
stress.34–36 While these clinical studies suggest that the use of
high concentrations of inspired oxygen in this context may be
safe, further studies are required to calculate the risk benefit ratio
and determine whether such therapy has a beneficial impact on
patient outcome. Such data may permit rational design of future
clinical trials.
While evidence of significant changes in brain oxygenation and
metabolism36 and suggestions that improved outcome may be
associated with targeted therapy are encouraging,21,37 a firm
recommendation for clinical use of the intervention requires a
clinical trial. Previous studies have suggested that hyperoxia
therapy in TBI can improve mortality, but not favorable outcome.38
A recently published phase II study from Rockswold et al36
provided valuable evidence of the risks and benefits of hyperoxia
therapy over several days. This study compared 60 minutes of
hyperbaric hyperoxia (1.5 atmospheres) with 3 hours of 100%
oxygen and standard care in a group of 69 patients with severe
head injury.36 Patients received therapy on three consecutive days
starting within 27 hours of injury and demonstrated some
evidence of an improvement in cerebral physiology that lasted
until the next treatment period. Importantly, there were no signs
of pulmonary or cerebral toxicity. A more recent publication from
the same group35 suggests that a combination of daily hyperbaric
(60 minutes at 1.5 atmospheres) followed by 3 hours of
normobaric hyperoxia (FiO2 1.0) can result in an increase in
favorable outcome.
Despite the promising findings, the studies by Rockswold et al
do not provide definitive evidence of an improvement in clinical
outcome.35,36 Evidence of a change in tissue fate may come from
DTI but evidence of improved outcome will require a large clinical
trial. Previous studies have shown serial DTI changes in gray and
white matter after head injury that represent microstructural
injury.9,10 Our study addressed this within the time frame of
metabolic changes that we have previously demonstrated with
short-term hyperoxia, but was only able to show improvement in
DTI parameters within a rim of potentially vulnerable tissue
around brain contusions.9 However, we can use the data from this
study and the recent Rockswold studies to refine the design of a
future therapeutic trial of hyperoxia therapy after clinical head
injury. In the studies published by Rockswold et al, subjects
received daily exposure to hyperoxia within the first 4 days after
injury, and we have shown that evolution of DTI signal changes
within pericontusional tissue is maximal within the first 72
hours.9,35,36,39 In our study, 9 of 14 subjects underwent interven-
tion within 72 hours of injury and only two subjects were studied
within 24 hours of injury. Previous studies have clearly demon-
strated that evidence of ischemia is more evident at earlier time
points after injury.1 However, derangements in brain metabolism
continue for many days after injury,14,25 may be particularly
prominent in white matter regions, and have shown evidence
of improvement after hyperoxia therapy.2,35,36,39 In our study,
changes in DTI parameters did not differ between those subjects
imaged at earlier compared with later time points (P¼ 0.32). While
Rockswold et al39 used daily exposures of normo and hyperbaric
hyperoxia, the subjects in our study only underwent an
intervention lasting approximately 1 hour using an FiO2 of 0.8.
Clearly, the partial pressure of oxygen delivered and the duration
of exposure may be relevant in determining the impact on
outcome but we must balance the potential benefits with the lack
of robust safety data beyond 3 days’ worth of treatment.
Future studies should seek to confirm whether exposing
patients with brain injury to high fractions of inspired oxygen
during management of raised ICP over a period of several days is
beneficial. This could cover an initial period of 72 hours, but
should be reviewed should further management for raised ICP be
required. Assessment could focus on DTI progression around
cerebral contusions and within white matter regions as an
intermediate endpoint, and as a cause of neurocognitive deficits
at outcome.40,41 This would require a longitudinal study with
imaging at regular intervals and correlation with structural
imaging at outcome and neurocognitive assessment at 6 to 12
months after injury. Such evidence would be useful in the design
of any future large clinical trial. We have previously reported on
the reproducibility of DTI measurements42 and found that for ADC
the s.d. of ROI measurements was 3.16 10 5mm/second. Using
such data to calculate sample sizes for interventional and
longitudinal clinical studies, we should be able to detect a 10%
change in ADC with 95% power at a significance level of 1%
within a group of 15 subjects within a single interventional or
longitudinal study design.42
CONCLUSIONS
Previous studies have suggested that cerebral metabolism can be
improved through an increase in the fraction of inspired oxygen.
Using DTI we demonstrate that a short interval of normobaric
hyperoxia may result in benefit within the rim of cytotoxic edema
around brain contusions. Future longitudinal studies should
address whether a longer period of hyperoxia therapy during
the time that patients require critical care management of raised
ICP has a favorable impact on the evolution of tissue injury. Such
data would help inform the design of future clinical trials of
targeted oxygen therapy for patients with head injury.
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